Today's pre-market stock movers: JELD, BILI, NIO, XPEV and more

• $Innoviz Technologies(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)

• $Hilltop Holdings(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest using available cash on hand)

• $Supernus Pharmaceuticals(SUPN.US)$ +5.91% (receives FDA approval for Qelbree)

• $NextDecade(NEXT.US)$ +4.47% (announces the execution of a 15-year sale and purchase agreement with ENGIE S.A. for the supply of liquefied natural gas from NextDecade's R.io Grande LNG export project in Brownsville Texas)

• $Myovant Sciences(MYOV.US)$ +2.9% (receives EC approval for ORGOVYX)

• $Ouster(OUST.US)$ +2.4% (entered into $150 mln common stock At Market Issuance Sales Agreement)

• $Eargo(EAR.US)$ +2.56% (provides QI shipment data; reaches settlement agreement with DOJ)

• $PureCycle Technologies(PCT.US)$ +2.3% (files for 33132056 share common stock offering by selling shareholders)

• $Akoustis Technologies(AKTS.US)$ +2%（earnings reports）

• $Saia(SAIA.US)$ +1.9%（earnings reports）

• $IDEAYA Biosciences(IDYA.US)$ +1.7% (receives Orphan Drug Designation for darovasertib a PKC inhibitor for the treatment of uveal melanoma)

• $Spirit Airlines(SAVE.US)$ +1% (JetBlue (JBLU) submits enhanced superior proposal to acquire Spirit for $33 cash per share)

• $Griffon(GFF.US)$ +4.2% (upgraded to Strong Buy from Outperform at Raymond James)

• $New Oriental(EDU.US)$ +2.2% (upgraded to Neutral from Underweight at JP Morgan)

• $EPAM Systems(EPAM.US)$ +2% (upgraded to Overweight from Neutral at Piper Sandler)

• $Comerica(CMA.US)$ +1.7% (upgraded to Overweight from Neutral at Piper Sandler)

• $Empire State Realty Trust Inc(ESRT.US)$ +1.2% (upgraded to Outperform from In-line at Evercore ISI)

• $Hutchmed (China)(HCM.US)$ -18.49% (receives Complete Response Letter from the U.S. FDA for surufatinib for the treatment of advanced neuroendocrine tumors)

• $JELD-WEN Holding(JELD.US)$ -8.6%（earnings reports）

• $Moody's(MCO.US)$-7.7%（earnings reports）

• $Bilibili(BILI.US)$ -5.88%（earnings reports）

• $Navient(NAVI.US)$ -4.7% (President Biden considering cancelling at least $10,000 in student loan debt for people with incomes below $150K)

• $Milestone Pharmaceuticals(MIST.US)$ -3.3% (Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT)

• $NIO Inc(NIO.US)$ -2.7% (reports April deliveries)

• $Coherus BioSciences(CHRS.US)$ -2.7% (Coherus BioSciences and Junshi Biosciences receive Complete Response Letter from U.S. FDA for toripalimab BLA)

• $Tarsus Pharmaceuticals(TARS.US)$ -2.2% (announces $50 mln underwritten public offering of common stock)

• $Li Auto(LI.US)$ -2.1% (reports April deliveries)

• $Axsome Therapeutics(AXSM.US)$ -2% (FDA issues CRL regarding company's NDA for AXS-07 for acute treatment of migraine)

• $XPeng(XPEV.US)$ -2% (reports April deliveries).

• $Community Bank System(CBU.US)$ -0.7% (downgraded to Underweight from Neutral at Piper Sandler)